Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.
Saved in:
| Title: | Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference. |
|---|---|
| Authors: | Laurent PA; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; INSERM, U1030 'Molecular Radiotherapy and Therapeutic Innovations', Gustave Roussy, Villejuif, France., André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; INSERM U981 'Molecular predictors and new targets in oncology', Gustave Roussy, Villejuif, France.; IHU PRISM Precision Medicine Cancer Center, Gustave Roussy, Villejuif, France., Bobard A; SIRIC EpiCURE, Gustave Roussy, Villejuif, France., Deandreis D; Division of Nuclear Medicine, Gustave Roussy, Villejuif, France., Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New-York, NY, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New-York, NY, USA.; Sandra and Edward Meyer Cancer Center, New York, NY, USA., Depil S; Cancer Research Center of Lyon, Centre Léon Bérard, Université Claude Bernard, Lyon, France.; ErVimmune, Lyon, France., Eichmüller SB; Research Group GMP & T-cell therapy, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany., Fernandez-Palomo C; Institute of Anatomy, University of Bern, Bern, Switzerland., Foijer F; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Galluzzi L; Department of Radiation Oncology, Weill Cornell Medicine, New-York, NY, USA.; Sandra and Edward Meyer Cancer Center, New York, NY, USA.; Caryl and Israel Englander Institute for Precision Medicine, New York, NY, USA., Galon J; INSERM, Laboratory of Integrative Cancer Immunology; Sorbonne Université; Sorbonne Paris Cité, Université de Paris, Paris, France.; Centre de Recherche des Cordeliers, Paris, France., Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland., Harrington KJ; The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, National Institute of Health Research Biomedical Research Centre, London, UK., Herrera FG; Radiation Oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Huber PE; Department of Radio-oncology and Radiotherapy, University Hospital Heidelberg; Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany.; Department of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Italiano A; Department of therapeutic innovations (DITEP), Gustave Roussy, Villejuif, France.; Department of Medicine, Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Karam SD; Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Kroemer G; Centre de Recherche des Cordeliers, Université de Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France.; Department of Biology, Hôpital Européen Georges Pompidou AP-HP, Paris, France.; Institut du Cancer Paris CARPEM, Paris, France., Lambin P; Department of Precision Medicine, GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.; Department of Radiology and Nuclear Medicine, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., Leuschner C; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mantovani A; IRCCS Humanitas Research Hospital, Rozzano, MI, Italy.; William Harvey Research Institute, Queen Mary University, London, UK., Meylan E; Laboratory of Immunobiology, Department of Molecular Biology, Faculty of Sciences, Université Libre de Bruxelles, Bruxelles, Belgium.; Lung Cancer and Immuno-Oncology laboratory, Bordet Cancer Research Laboratories, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Faculty of Medicine, Université libre de Bruxelles, Bruxelles, Belgium.; ULB Cancer Research Center (U-CRC) and ULB Center for Research in Immunology (U-CRI), Bruxelles, Belgium., Mondini M; INSERM, U1030 'Molecular Radiotherapy and Therapeutic Innovations', Gustave Roussy, Villejuif, France., Pittet MJ; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; AGORA Cancer Research Center, Lausanne, Switzerland. Swiss Cancer Center Leman, Lausanne, Switzerland.; Translational Research Center in Onco-Haematology (CRTOH), University of Geneva, Geneva, Switzerland.; Department of Oncology, Geneva University Hospitals (HUG), Geneva, Switzerland., Pouget JP; Institut de Recherche en Cancérologie de Montpellier (IRCM)INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France., Remon J; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Sørensen CS; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark., Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Vanpouille-Box C; Department of Radiation Oncology, Weill Cornell Medicine, New-York, NY, USA.; Sandra and Edward Meyer Cancer Center, New York, NY, USA., Weichselbaum RR; Department of Radiation and Cellular Oncology, Ludwig Center for Metastasis Research; University of Chicago, Chicago, IL, USA., Welsh JW; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zitvogel L; ClinicObiome, Gustave Roussy, Villejuif, France.; INSERM U1015 'Tumor Immunology and Anti-Cancer Immunotherapy Unit', Gustave Roussy, Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.; Division of Medicine, Paris-Saclay University, Ile-de-France, France., Formenti SC; Department of Radiation Oncology, Weill Cornell Medicine, New-York, NY, USA.; Sandra and Edward Meyer Cancer Center, New York, NY, USA., Deutsch E; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; INSERM, U1030 'Molecular Radiotherapy and Therapeutic Innovations', Gustave Roussy, Villejuif, France.; Division of Medicine, Paris-Saclay University, Ile-de-France, France.; RHU LySAIRI 'Lymphocyte-Sparing Artificial Intelligence-guided Radio-Immunotherapy', Gustave Roussy, Villejuif, France. |
| Source: | Oncoimmunology [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2432726. Date of Electronic Publication: 2024 Dec 18. |
| Publication Type: | Conference Proceedings |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
